The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Animal Drug Compounding Market During The 2026–2030 Period?
The animal drug compounding market has experienced substantial expansion in recent years. Projections indicate it will expand from $1.79 billion in 2025 to $1.91 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. Historically, this growth has been driven by factors such as the increasing incidence of chronic illnesses in pets, a rise in visits to veterinary clinics, the need for adaptable dosage options, the expanding population of companion animals, and the development of veterinary pharmaceutical enterprises.
The animal drug compounding market is anticipated to experience robust expansion in the coming years. Its valuation is projected to reach $2.58 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.8%. This projected growth throughout the forecast period stems from factors such as advancements in drug compounding technologies, the increasing adoption of AI for personalized medicine, an increase in livestock treatment applications, heightened recognition of customized veterinary therapies, and the broader integration of veterinary diagnostics. Key trends anticipated during this period involve a rising need for personalized veterinary medications, the wider availability of injectable and oral compounded drugs, an intensified focus on the well-being of companion animals, the merging of veterinary diagnostics with drug compounding practices, and the uptake of tailored hormonal and anti-inflammatory treatments.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9964&type=smp
Which Significant Factors Are Encouraging Growth In The Animal Drug Compounding Market?
Rising pet expenditure is expected to propel the growth of the animal drug compounding market going forward. Pet expenditure refers to the total amount of money spent on various expenses related to owning and caring for a pet. Pet expenditure contributes to the demand for tailored medications that cater to the unique needs of individual animals, thereby encouraging compounding pharmacies to continue providing these specialized services in veterinary care. For instance, in October 2023, the North American Pet Health Insurance Association (NAPHIA), a US-based trade organization published that in 2022, pet owners in the United States spent $136.8 billion on their dogs, cats, birds, and other companion animals, and this amount is projected to rise to $143.6 billion in 2023. Therefore, rising pet expenditure drives the animal drug compounding market.
What Segment Categories Are Evaluated In The Animal Drug Compounding Market Study?
The animal drug compounding market covered in this report is segmented –
1) By Animal Type: Companion Animals, Livestock Animals
2) By Product: Anti-Infective Agents, Anti-inflammatory Agents, Hormones And Substitutes, CNS Agents, Other Products
3) By Route Of Administration: Oral, Injectable, Topical, Other Routes Of Administrations
4) By Application: Veterinary Hospitals, Veterinary Clinics, Veterinary Diagnostic Centers
Subsegments:
1) By Companion Animals: Dogs, Cats, Horses
2) By Livestock Animals: Cattle, Swine, Poultry, Sheep, Goats
What Trends Are Affecting The Growth Of The Animal Drug Compounding Market?
Major companies in the animal drug compounding market are developing innovative products, including feline-friendly formulations, to enhance the safety and effectiveness of medications tailored specifically for cats. Feline-friendly formulations refer to products specifically designed to be safe, effective, and appealing for cats. For instance, in September 2024, Wedgewood, a US-based veterinary pharmaceutical company launched compounded molnupiravir. Compounded molnupiravir is an antiviral drug specifically for treating Feline Infectious Peritonitis (FIP) in cats. It offers feline-friendly formulations of molnupiravir, available in various dosages designed to treat different forms of FIP, including effusive, non-effusive, neurological, and ocular types. This involves producing different dosages and flavors, including flavored oral oil suspensions and capsules, to meet the specific requirements of individual feline patients.
Who Are The Key Market Participants In The Animal Drug Compounding Market?
North America was the largest region in the animal drug compounding market in 2025. The regions covered in the animal drug compounding market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access The Complete Animal Drug Compounding Market Report:
https://www.thebusinessresearchcompany.com/report/animal-drug-compounding-global-market-report
Which Region Stands As The Largest Contributor To The Animal Drug Compounding Market?
North America was the largest region in the animal drug compounding market in 2025. The regions covered in the animal drug compounding market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Animal Drug Compounding Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=9964&type=smp
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model